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Connexin31.1 (Cx31.1) is a gap junction protein associated with apoptosis. In the
skin, apoptosis is modulated by diabetes. A HaCaT skin model investigated whether
normal (NGI) and high glucose and insulin (HGI; diabetic) conditions altered Cx31.1
expression, and if these were apoptosis linked. Cx31.1 was found in HaCaT and
HeLa Ohio cells, with HaCaT Cx31.1 protein increased in HGI conditions, and
around apoptotic cells. HeLa Cx31.1 channels were noncommunicative. Post scrape‐
wounding, Cx31.1 increased at wound edges. Caspase 3/7 in scrape‐wounds media
(containing cells) elevated in HGI. UV exposure raised Cx31.1, and caspase 3/7, in
NGI and HGI. UV reduced cell viability in NGI cells, although not significantly in HGI.
Cx31.1 is modulated during HaCaT cell wound closure, and associated with ‘diabetic’
conditions. Cx31.1 expression matched apoptosis levels, higher in HGI cultures.
Cx31.1 is noncommunicating, modulated after wounding, linked to apoptosis, and
may be associated with tissue turn‐over around diabetic wounds.
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1 | INTRODUCTION
In diabetes, wound healing is compromised and wounds often fail to
close, resulting in diabetic ulcers which are difficult to heal and costly
to treat. Gap junction expression is well‐documented to be com-
promised in diabetic skin and chronic wounds, and failure of gap
junction intercellular communication, essential in coordinating
wound healing, is a contributing factor to ulcer formation (Becker,
Thrasivoulou, & Phillips, 2012; Martin, Easton, Hodgins, &
Wright, 2014; J. A. Wright, Richards, & Becker, 2012). Connexins are
a family of transmembrane proteins that assemble to form connexons
or hemichannels in the plasma membrane. Pairs of connexon chan-
nels dock making gap junctions, which directly link the cytoplasm of
adjoining cells, allowing them to communicate. Inorganic ions, small
metabolites, and cellular signalling molecules (<1 kDa in size)
are exchanged between cells via these gap junctions (Evans &
Martin, 2002; Laird, 2006). This allows for cells within a tissue to
coordinate their processes, and they are important in many organs
such as the heart, brain and skin.
In the skin, the epidermis is avascular and gap junction commu-
nication is important in epidermal barrier integrity, epidermal stem
cell function, and keratinocyte terminal differentiation pathways
(Mascre et al., 2012). Up to 10 connexin subtypes are differentially
expressed in the skin in various layers with connexin43 (Cx43) pre-
dominating: 9 connexins in the epidermis and 3 in the dermis (Martin
et al., 2014). Cx31.1 is expressed in the epidermal spinous and
granular layers (Di, Rugg, Leigh, & Kelsell, 2001; Gibson, Bikle, Harris,
& Goldberg, 1997; Hennemann et al., 1992). Connexin expression
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levels in HaCaT cells (a human keratinocyte cell line) are similar to
those found in human keratinocytes and they are a frequently used
model for epidermal skin cells (Boukamp et al., 1988). During skin
wound healing, distribution patterns of Cx43 and Cx26 are re-
modelled, and Cx43 is a therapeutic target to improve wound closure
(reviewed by Becker et al., 2012). In diabetic wound healing, Cx43
and Cx26 levels do not change as expected, which may be related to
wound closure failure. Alongside these major players, reports show
that Cx30, Cx31, and Cx31.1 can also be dynamically regulated
during wound repair (Goliger & Paul, 1995).
Cx31.1 is a less well‐studied connexin, but appears to have roles in
cell and tissue turn‐over. In the eye (Chang et al., 2009) and ovary
(Wright, Becker, Lin, Warner, & Hardy, 2001), its expression is asso-
ciated with apoptosis, and it is thought to form gap junctions which are
nonfunctional and not communicative. The role of Cx31.1 in skin
function and wound healing is not defined, however, and tissue turn-
over is compromised around diabetic wound edges, where epidermal
hyperproliferation occurs. Cx31.1 may be involved in this aberrant
tissue turnover. Different mechanisms can affect cell proliferation and/
or migration during wound closure, and prevent it. In diabetic wounds,
one of these factors could be regulation and expression of Cx31.1.
This study investigated whether Cx31.1 expression was altered
in HaCaT scrape‐wounded monolayers cultured in normal (NGI) and
high glucose and insulin (HGI) and if this was associated with
UV‐induced apoptosis. Culture conditions mimicking the environ-
ment cells would be exposed to in normal and untreated type II
diabetic conditions, where high circulating levels of glucose and in-
sulin occur. We propose that levels of Cx31.1 and apoptosis are
different in normal and diabetic skin following wounding, and are
thus contributing factors in delayed diabetic wound healing.
2 | MATERIALS AND METHODS
2.1 | Cell sources and culture
HaCaT and HeLa Ohio cells were obtained from Cell Lines Services
(Eppelhiem, Germany) and the European Collection of Authenti-
cated Cell Cultures (via Merck/Sigma Aldrich, Gillingham, UK), re-
spectively. Human dermal neonatal fibroblast cells were obtained
from Invitrogen (Paisley, UK). Cells were maintained in euglycaemic
Dulbecco's modified Eagle's medium (DMEM) containing 5.5 mM
glucose supplemented with 10% vol/vol fetal bovine serum, 2 mM
glutamine, 50 U/ml penicillin, and 50 U/ml streptomycin (all Lonza,
Wokingham, UK). This complete media was known as cDMEM. To
mimic ‘normal’ and ‘type II diabetic’ levels of glucose and insulin in
the skin, following plating, HaCaT cells were treated daily for a
minimum of 5 days with 5.5 mM glucose, 1 nM insulin and 0.1%
bovine serum albumin (BSA; normal glucose and insulin [NGI] con-
ditions), or 25mM glucose, 10 nM insulin, and 0.1% BSA (high glu-
cose and insulin [pHG] conditions) in DMEM before experiments
being carried out (Bagdade, Bierman, & Porte, 1967; Spravchikov
et al., 2001;Wright, Berends, Flint, & Martin, 2013). This regime
allowed preconditioning of the cells to ‘normal’ and ‘diabetic’ cel-
lular environments, and has been shown by other studies to change
gene expression, for example, Cx43 increases (Wright et al., 2013),
such that a diabetic phenotype is mimicked by the HGI treatment,
which is similar to that seen in primary skin cells from patients with
diabetes Levels of insulin and glucose used here represent that seen
in the skin of type II diabetic patients who are not receiving
treatment (Bagdade et al., 1967).
2.2 | Ultra violet exposure of HaCaT cells
For induction of apoptosis in some HaCaTs, cells were grown to con-
fluence in a 96‐well plate and pretreated with NGI and HGI as above.
Culture medium was removed from the cells, replaced by phosphate
buffered saline (PBS), and they were exposed to 4,000 µW/cm2 ultra
violet (UV) light in a UV Crosslinker (Thermo Fisher Scientific, Lough-
borough, UK) for 1min. Culture medium was replaced, the cells re-
turned to the incubator, and the relevant assay carried out 18 hr later.
For the control group, the media in dishes were replaced with PBS as
above, but half of the plate was then covered and only the other half of
the plate was exposed to the UV light. The media were then re-
plenished and the dishes returned to the incubator.
2.3 | Western blot analysis
To test whether Cx31.1 was expressed in HeLa Ohio cells, western
blot analysis was carried out. Cells (1 × 106) were plated onto six‐well
plates, grown to subconfluence, and harvested. Western blot analysis
was performed as in (Easton, Petersen, & Martin, 2009). The primary
antibody was a rabbit polyclonal Cx31.1 antibody (1:1,000; custom
made for Prof. Colin Green, University of Auckland, New Zealand)
and a rabbit polyclonal glyceraldehyde 3‐phosphate dehydrogenase
(GAPDH) antibody (diluted 1:10,000; Abcam, Cambridge, UK). Blots
were developed using Uptilight™ High WB Chemiluminescent
Substrate (Cheshire Sciences [UK] Ltd, Chester, UK) and analysed via
a LI‐COR Odyssey system (LI‐COR, Cambridge, UK).
2.4 | Gap junction functionality assays
To assess whether there were functional gap junctions in Hela Ohio
cells, scrape load assays were first performed. Cells were grown to
confluence in a 60mm dish, washed in PBS, and then scraped with a
200 μl pipette tip. A 1:200 dilution of Alexa Flour 488 or Alexa Flour
594 dye (equivalent to 5 μg/ml; Invitrogen, Paisley, UK) was added and
left for 5min. The cells were washed in PBS and fixed with 3.7% par-
aformaldehyde. After 5min, the cells were washed in PBS. Images were
then taken with a LSM800 confocal microscope (Zeiss, Cambridge, UK).
Gap junction functionality was further assessed by parachute
assay (Stains & Civitelli, 2016). HeLa Ohio or HeLa43 cells (HeLa cells
stably transfected with Cx43) were seeded onto cover‐chambers and
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six‐well plates, respectively, at 1 × 106 cells per well. Briefly, cells
were live‐stained with 2.5 mM calcein‐AM and layered at a ratio of
1:50 onto cells live‐stained with 1mg/ml CM‐Dil (Invitrogen) and
incubated at 37°C for 4 hr. Some HeLa43 cells were treated with
100 µM carbenoxolone to block gap junctional intercellular commu-
nication (GJIC). Dye transfer was assessed using confocal microscopy
by detecting dye spread from the green‐stained donor cells into the
red‐stained acceptor cells, the average percentage of cells receiving
calcein‐AM being calculated (Martin, Wall, & Griffith, 2005).
2.5 | Quantitative real‐time polymerase chain
reaction
HaCaTs were plated onto six‐well plates (1 × 106 cells/well), grown to
confluence and preconditioned with NGI or HGI for 5 days. mRNA
was extracted with an RNeasy plus mini kit (Qiagen, Crawley, UK),
and quality assessed with a Nanodrop (Thermo Fisher Scientific).
Reverse transcription was carried out on 1 μg mRNA per reaction
with reverse transcriptase (Roche, Welwyn Garden City, UK) ac-
cording to the manufacturer's instructions. Taqman‐type qPCR was
carried out using primers and probes to human Cx31.1 in comparison
with human GAPDH as a control.
Human Cx31.1 qPCR primers and probes (IDT, Leuven, Belgium)
were forward primer: TGTGTGGAGTGATGACCACAAGGA, reverse
primer: ACATGGGACACAGGGAAGAACTCA and probe: CCGGCT
GCTCCAACGTCTGCTTTGA. Human GAPDH primers and probes
were forward primer: CACATGGCCTCCAAGGAGTAA, reverse pri-
mer: TGAGGGTCTCTCTCTTCCTCTTGT, and probe: CTGGACCA
CCAGCCCCAGCAAG.
2.6 | Scrape‐wound assays and
immunocytochemistry
HaCaTs were seeded on glass coverslips at 1 × 106/ml in 12‐well
plates, and grown to confluent monolayers in NGI or HGI. After
treatment, scrape‐wounds were introduced with a 100 μl pipette tip
and cell migration monitored (Wright, van Steensel, Hodgins, &
Martin, 2009). Cells were fixed at 0, 24, and 48 hr with 100% ice cold
methanol. Immunocytochemistry was carried out as described pre-
viously (Wright et al., 2009). Anti‐rabbit polyclonal primary anti-
bodies diluted with filtered PBS were used: anti‐Cx31.1 was diluted
1:500. Anti‐active caspase 3 (Promega, Southampton, UK) was used
at 1:250. Secondary antibodies were goat anti‐rabbit Alexa Flour 488
(diluted 1:500; equivalent to 2 μg/ml; Invitrogen) and Alexa Flour
594 (1:500; Invitrogen) for Cx31.1 and active caspase 3, respectively.
Cell nuclei were labelled with 10 μg/ml 4′,6‐diamidino‐2‐
phenylindole (Invitrogen) and images taken via confocal microscopy
(Wright et al., 2009). Similar immunocytochemistry for Cx31.1 ex-
pression detection was carried out on HeLa Ohio cells. Pixel intensity
analysis was carried out via the ImageJ software (NIH) on three
independent images for each condition.
2.7 | Caspase 3/7 assays
Caspase 3/7 activity was either measured in NGI‐ or HGI‐treated
HaCaTs (5 × 104 cells/ml) in 96‐well plates, or in conditioned media
which contained free‐floating apoptotic cells. Caspase 3/7 was
measured using the Caspase‐Glo 3/7 kit (Promega) and luminescence
was measured on a Flourstar Optima microplate reader (BMG
Labtech, Aylesbury, UK).
2.8 | Cell viability assay
HaCaT cell viability was measured by the 3‐(4,5‐dimethylthiazol‐2‐
yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) absorbance assay. About
5mg/ml of MTT stock (Fisher) was added to NGI or HGI‐treated cells
plated at 5 × 104 cells/ml in a 96 well plate and incubated for 1 hr.
Dimethyl sulfoxide was added to solubilise the cells, and the plate
was read for absorbance at 570 nm on a Floustar Optima microplate
reader (BMG Labtech, Aylesbury, UK).
2.9 | Statistical analysis
All experiments were done a minimum of three times (n ≤ 3).
Normalisation of data was carried out in Excel. Results were com-
piled into the GraphPad Prism software (GraphPad Software Inc, La
Jolla, CA) and all data is expressed as mean ± standard error of mean.
Statistical analysis was performed on the data using a paired t test
with statistical significance inferred at p < .05 for all experiments.
3 | RESULTS
3.1 | Cx31.1 is expressed in HeLa Ohio and HaCaT
cell membranes
HeLa Ohio cells have been reported not to express any other con-
nexin subtypes at appreciable mRNA or protein levels (Eckert,
Dunina‐Barkovskaya, & Hulser, 1993; Mesnil et al., 1995). They are
often used as a vehicle for connexin transfection for this reason. To
determine whether Cx31.1 specifically was expressed in HeLa Ohio,
HaCaT and neonatal dermal fibroblast cells, and western blot ana-
lysis was carried out (Figure 1a). This revealed that Cx31.1 protein
was expressed in HeLa Ohio cells and in HaCaT cells, although not in
dermal fibroblasts. Cx31.1 was not previously known to be expressed
in HeLa Ohio cells, so this is a novel result.
3.2 | HeLa Ohio cells do not transfer dye
between them
To test whether dye transferred through cell layers, indicating GJIC,
HeLa Ohio cells were scrape‐loaded with Alexa Flour dye. This
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indicated whether the low levels of Cx31.1 expressed by HeLa Ohio
cells were able to form functional communicating channels. There
was no significant dye transfer between the cells (Figure 1b,c), thus
GJIC was not active, confirming previous data. In further dye transfer
studies (Figure 1d), a parachute assay showed that donor HeLa Ohio
cells do not transfer Calcein‐AM dye to acceptor cells, whereas in
HeLa43 cells, dye was transferred to four cells on an average
(Figure 1d). HeLa43 cells blocked with 100 µM carbenoxolone ex-
hibited similar levels of transfer to HeLa Ohio cells alone. We can
therefore confirm that in HeLa Ohio cells, Cx31.1 does not form
functional gap junctions, and this can be extrapolated to HaCaT cells.
3.3 | Cx31.1 expression is raised in ‘diabetic’
conditions and after UV exposure
HaCaT cells were treated with NGI or HGI media for 5 days to si-
mulate normal and ‘diabetic’ conditions. Five days of pretreatment to
cells in this way has previously been shown to induce gene expres-
sion (Wright et al., 2013) and to mimic diabetic‐induced changes to
connexins and other proteins (Pollok et al., 2011; Spravchikov
et al., 2001; Wright, Pollok, Flint, Brandner, & Martin, 2012). qPCR of
Cx31.1 gene expression was performed and normalised to GAPDH
expression. This showed that there was a small (though not statisti-
cally significant) increase in Cx31.1 mRNA expression in HGI com-
pared to NGI treatment (Figure 2a).
Immunocytochemistry revealed Cx31.1 protein expression (green
punctate staining) on cell membranes in areas of cell‐cell contact and
on membranes without contact as well (Figure 2b,c). There was also
some cytoplasmic labelling of Cx31.1 in HGI‐treated cells apparent as
intracellular speckles. HaCaTs treated with HGI showed higher levels
of expression of Cx31.1 protein compared to those treated with NGI,
and this was confirmed by pixel intensity analysis (Figure 2f). In
addition, Cx31.1 was particularly apparent around apoptotic cells
where often nuclei had broken down. Figure 2d shows Cx31.1 dif-
ferentially expressed around an apoptotic cell, as defined by nuclear
shape, exhibiting higher levels of membrane Cx31.1 compared to the
normal cells around it. HeLa Ohio cells showed a low level of Cx31.1
expression on the cell membranes. This appeared to be on healthy
cells as well as those undergoing cell death.
3.4 | UV exposure of human skin is a key mediator
of apoptosis
To determine if apoptosis of HaCaT cells that was initiated by UV
exposure (as would occur to epidermal keratinocytes in human skin on
sun exposure) would affect Cx31.1 expression, cells were cultured in
NGI or HGI, exposed to UV, and then underwent immunocytochemistry.
Figure 2e shows that Cx31.1 expression was increased in both NGI‐ and
HGI‐treated cells by UV exposure. This was confirmed by pixel intensity
analysis of the Cx31.1 expression which showed a nonsignificant in-
crease after UV treatment for NGI treated cells, but a significant rise for
HGI treated cells (p < .05; Figure 2f).
3.5 | Cx31.1 and apoptosis are modulated during
scrape‐wounding
The HaCaTs were scrape‐wounded and Cx31.1 expression examined
post‐wounding (Figure 3a). Cells migrated over the denuded area
over the next 48 hr. In comparison with just after wounding (0 hr),
Cx31.1 expression at wound edges is increased at 24 and 48 hr in
both NGI‐ and HGI‐treated cells, with higher levels of Cx31.1 in HGI
conditions compared to NGI conditions at all time‐points. In addition,
there was greater intracellular speckling of Cx31.1 within the
F IGURE 1 (a) Western blot analysis for Cx31.1 in HeLa Ohio, dermal fibroblasts, and HaCaT cells, showed Cx31.1 protein expression in all
cell types apart from dermal fibroblasts (negative control). (b) Scrape load assays with HeLa Ohio cells exposed to Alexa Flour 488 (1:500),
revealed no appreciable uptake of dye or dye transfer between the cell layers in cells scraped and PBS added, or where Alexa 488 was added (c).
(d) Calcein‐AM parachute assays showed that HeLa Ohio cells did not transfer dye from donor to acceptor cells via GJIC, whereas in HeLa43
cells dye was transferred to four cells on average (***p < .001). HeLa43 cells blocked with 100 µM carbenoxolone exhibited similar levels of gap
junctional coupling as HeLa Ohio cells alone (n = 3, paired t test). GAPDH, glyceraldehyde 3‐phosphate dehydrogenase; GJIC, gap junctional
intercellular communication; PBS, phosphate buffered saline
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cytoplasm of HGI cells—suggestive of internalised Cx31.1. To ex-
amine levels of apoptosis in scrape‐wounded HaCaTs, we examined
active caspase 3 which should only be expressed in cells undergoing
apoptosis (Figure 3b). Active caspase 3 expression increased 24 hr
after scrape‐wounding in both NGI‐ and HGI‐treated HaCaTs. This
resolved by 48 hr postwounding. Thus there is some correlation be-
tween Cx31.1 and caspase 3/7 expression at the wound margins.
Caspase 3/7 activity (indicating levels of apoptosis) was mea-
sured in conditioned media containing apoptotic HaCaT cells ob-
tained over the course of scrape‐wound closure (Figure 4a). At 0 and
24 hr following the scrape‐wound, the HGI media+cells contained
higher levels of caspase activity than NGI media+cells (p < .05).
However, this difference resolved at 48 hr. Caspase 3/7 is late
marker of apoptosis, and caspase 3 is a common end point of the
caspase assay cascade occurring after UV damage via death receptor
activation, reactive oxygen species activation, and Bax translocation
(C. H. Lee, Wu, Hong, Yu, & Wei, 2013).
3.6 | UV treatment increases apoptosis and
decreases cell viability
To examine differences in susceptibility to apoptosis of HaCaT cells
in normal and ‘diabetic’ conditions, some cells were exposed to UV
F IGURE 2 (a) Fold change of Cx31.1 expression via qPCR in HaCaTs treated with HGI versus NGI normalised to GAPDH. There was is a
nonstatically significant increase in HGI conditions compared to NGI on Cx31.1 mRNA (n = 5). (b,c) Immunocytochemistry of Cx31.1 (green
punctate staining) in HaCaTs with DAPI stained nuclei (blue) showed Cx31.1 was present on cell membranes, with some cytoplasmic labelling in
HGI‐treated cells. HaCaTs treated with HGI showed higher levels of Cx31.1 expression compared to those treated with NGI. (d) In untreated
cells cultured in cDMEM Cx31.1 was apparent at a higher level around apoptotic cells (*), as defined by nuclear shape, where often nuclei had
broken down, compared to healthy cells. (e) Expression of Cx31.1 in HaCaTs cultured in normal and ‘diabetic’ conditions pre‐ and postexposure
to UV, that stimulated apoptosis pathways. UV exposure increased the levels of Cx31.1 in both NGI and HGI treated cells. (f) Relative pixel
intensity measurement of Cx31.1 expression by immunocytochemistry confirmed an increase (p < .05) in Cx31.1 with both NGI and UV
treatment (n = 3). Scale bars = 100 µm (c,d) or 10 µm (e). DAPI, 4′,6‐diamidino‐2‐phenylindole; DMEM, Dulbecco's modified Eagle's medium;
GAPDH, glyceraldehyde 3‐phosphate dehydrogenase; HGI, high glucose and insulin; NGI, normal glucose and insulin; qPCR, qualitative
polymerase chain reaction
NUGENT ET AL. | 5
(Figure 4b). UV exposure significantly increased caspase 3/7 activity
in both NGI‐ (p < .001) and HGI‐treated HaCaT cells (p < .05). How-
ever, HGI‐treated cells showed reduced caspase activity compared to
NGI‐treated cells before UV exposure (p < .01).
In parallel to the apoptosis assays, the MTT cell viability assays
determined there was reduced cell viability following UV exposure in
NGI‐treated cells compared to cells tested before UV exposure
(p < .001). This did not occur in HGI‐treated cells, although there was
a similar trend (Figure 4c).
4 | DISCUSSION
Cx31.1 is a connexin subtype associated with apoptosis in organs
such as the eye and ovary (Chang et al., 2009; Wright et al., 2001);
however, it is not highly expressed in many tissues in normal con-
ditions. It has also been unclear whether Cx31.1 makes functional
communicating channels, and so if its expression may indicate a
specific cell signalling route, or if blocks cell signalling, by closing
down (Harris, 2001). In this study, we examined Cx31.1 expression in
HaCaT cell model of the human epidermis, to investigate whether
induction of apoptosis by UV exposure and culture in ‘normal’ and
‘diabetic’ skin conditions would influence Cx31.1 expression. Fur-
thermore, we used HeLa Ohio cells to determine if Cx31.1 channels
were open and functional.
We discovered that Cx31.1 protein was expressed at low levels
in HeLa Ohio cell membranes (Figure 1), although it does not form
communicating gap junctions when assessed by dye transfer assays.
This fits similar studies where Cx31.1 has been found to be non-
communicative or at least rarely forms functional gap junction
channels either with itself or other connexin isoforms (Harris, 2001).
We then investigated possible perturbations in Cx31.1 expression
before and during scrape‐wound healing. Cx31.1 was found to be
increased in HaCaT cell membranes exposed to high levels of glucose
F IGURE 3 (a) Immunocytochemistry of
Cx31.1 following scrape‐wounding of HaCaTs.
Dotted lines show the wound edges. Cx31.1 at
wound margins (green punctate staining,
indicated by arrows) increase at 24 and 48 hr
compared to 0 hr in both NGI and HGI, with
higher levels of Cx31.1 in HGI conditions
compared to NGI conditions. (b)
Immunocytochemistry of active caspase 3
indicating apoptosis cascade activation following
scrape‐wounding of HaCaTs. Active Caspase 3
(red staining) at wound edges was increased at
24 hr in both NGI and HGI conditions, indicating
that apoptosis levels increased to 24 hr and then
resolved. Scale bars = 100 µm. HGI, high glucose
and insulin; NGI, normal glucose and insulin
6 | NUGENT ET AL.
and insulin (mimicking those seen in the skin of people with un-
controlled type II diabetes) compared to normal levels (Figure 2b,c).
Cx31.1 levels were also higher on membranes of apoptotic rather
than viable cells. In addition, there was greater intracellular
“speckling” of Cx31.1 in cells cultured with HGI, which may represent
cleaved or internalised Cx31.1, although Cx31.1 does not have cas-
pase 3/7 cleavage sites and cleavage was not seen in western blots.
mRNA shows little change with HGI treatment (Figure 2a), thus
any differences seen in Cx31.1 protein expression are likely to be
posttranslational via high glucose levels increasing connexin
phosphorylation.
The increase in HaCaT Cx31.1 in ‘diabetic’ culture conditions
mirrors that seen in Cx43 and Cx26 exposed to high glucose and
insulin conditions in diabetic skin, suggesting that there is a com-
monality in effects of diabetic conditions on connexins (Becker
et al., 2012). Mechanisms that affect Cx43 in diabetic wound healing
are overexpression and reduction of channel function via phos-
phorylation (Solan & Lampe, 2014), leading to a fall in GJIC (Abdullah
et al., 1999; J. A. Wright et al., 2012). High levels of glucose and
insulin deleteriously affect Cx43‐containing gap junctions and hemi-
channels in human dermal fibroblasts (Wright et al., 2012) and ker-
atinocytes where HGI conditions increased phosphorylation of Cx43
at Ser368 leading to a reduced function (Wright et al., 2013). Cx31.1
may also become phosphorylated in diabetic conditions. There are
potential protein kinase C (PKC) binding sites predicted when the
human Cx31.1 sequence is analysed via NetPhos at positions 181,
210, 227, 234, 253, and 271 (NetPhos 3.1; Technical University of
Denmark). It is unclear, however, what effects this would have if
Cx31.1 forms noncommunicative junctions. Increased phosphoryla-
tion can enhance stability, or reduce attrition from the membrane
(Johnstone, Billaud, Lohman, Taddeo, & Isakson, 2012), so maintain-
ing Cx31.1 membrane expression may be the main effect.
UV‐triggered apoptosis in HaCaT cells increased Cx31.1 ex-
pression in cells which had been pretreated with both NGI and HGI
conditions (Figure 2e). UV exposure was chosen as a physiologically
relevant apoptosis trigger to mimic that seen in the epidermis fol-
lowing high amounts of sun exposure (C. H. Lee et al., 2013). Both the
‘diabetic’ treatment of cells and UV exposure were similar inducer
pathways stimulating Cx31.1 to form detectable membrane gap
junction plaques at significant levels (p > .05) above cells in non-
diabetic cells not exposed to UV.
Cx31.1 was modulated over the course of HaCaT scrape‐
wounding and healing (Figure 3a). Cx31.1 expression increased at
scrape‐wound edges at both 24 and 48 hr postwounding, during in-
jury repair, and was higher in HGI than NGI conditions. This is co-
incidental with the expression of active caspase 3 at 24 hr
(Figure 3b), which we propose represents tissue remodelling events
occurring in compartments at the wound edge. Apoptosis has an
important role in wound healing (Greenhalgh, 1998) by eliminating
cells that have been damaged by injury, or are not part of the
F IGURE 4 (a) Caspase 3/7 activity was measured in conditioned media containing apoptotic cells over the course of scrape‐wound closure,
and the data normalised. At 0 and 24 hr, HGI media+cells exhibited higher levels of caspase activity than NGI media+cells (*p < .05) during
scrape‐wound closure, but this resolved within 48 hr (n > 3; paired t test). (b) Caspase 3/7 apoptosis assays pre and post‐18 hr UV exposure.
Cellular caspase 3/7 activity revealed that UV exposure increased HaCaT apoptosis in NGI (***p < .001) and HGI (*p < .05) to a lesser extent
compared to cells not exposed to UV. (c) The MTT assay indicated that cell viability decreased in NGI (****p < .001), but not significantly in HGI
conditions, post‐UV exposure (n ≥ 3; paired t test). HGI, high glucose and insulin; NGI, normal glucose and insulin; MTT, 3‐(4,5‐dimethylthiazol‐
2‐yl)‐2,5‐diphenyltetrazolium bromide
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proliferating and migrating cells stimulated to close the wound.
Cx31.1 may assist this process. It is also possible that Cx31.1 con-
nexons are dispersed in the membrane (so not seen with im-
munocytochemistry), but with injury move into gap junction plaques,
to act as a channel blocker and/or apoptosis trigger. If, for example,
Cx31.1 connexons dock with Cx43 connexons, resulting heterotypic
channels would be nonfunctional.
The pattern of Cx31.1 changes in expression is opposite to that
seen in Cx43 modulation during scrape‐wound closure in human
primary skin cells (Wright et al., 2009), but implies that Cx31.1 is
involved in wound healing cascades. If Cx31.1 is nonfunctional, then
its increase may complement the decrease of Cx43 by acting in
concert to reduce wound edge GJIC, thus assisting cell migration and
wound closure (Martin et al., 2014). If the role of Cx31.1 is to close
down communication, then increased Cx31.1 expression con-
comitantly as Cx43 declines transiently fits with formation of a
wound edge communication compartment (Chanson, Watanabe,
O'Shaughnessy, Zoso, & Martin, 2018; Faniku et al., 2018) in which
GJIC is reduced, allowing cell migration and proliferation to be
stimulated.
Co‐ordinating to Cx31.1 increases, during scrape‐wound closure,
Caspase 3/7 activity was higher in HGI than NGI conditioned media
at 0 and 24 hr (Figure 4a). Caspase levels at 48 hr were similar in NGI
or HGI cultures, both increased from 0 hr. Caspase enzymes are part
of the execution phase of the apoptosis pathway, and so changes in
caspase 3/7 indicate changes in apoptosis levels (Al‐Mashat
et al., 2006). This fits with the observations that apoptosis levels in
diabetic skin are at an increased level to that seen in normal skin,
including wound margins (Al‐Mashat et al., 2006).
In HaCaTs, which were not wounded, cells showed different
responses to UV exposure, with cell viability (Figure 4b) and apop-
tosis levels (Figure 4c) being less affected by HGI pretreatment than
those in injured cells following scrape‐wounding. It may be that intact
cells can withstand UV insult better, or that since Caspase 3/7 is a
late apoptosis marker, the apoptosis induction window was missed.
Earlier markers of apoptosis could be examined in the future, such as
Annexin V. Despite the increased Cx31.1 seen with HGI treatment,
HGI preconditioning may have a UV protective effect unrelated to
Cx31.1 expression, likely to be associated with higher insulin levels
stimulating mitogenesis (Draznin, 2011).
Studies of Cx31.1 in the skin, and other systems, suggest that it is
associated with tissue turnover as well as apoptosis. This correlation has
been shown in human epidermal keratinocytes (Gibson et al., 1997). and
in oral keratinocytes. Cx31.1 was found to be responsive to retinoic acid
(Hatakeyama, Mikami, Habano, & Takeda, 2011), where reduced Cx31.1
was thought to be due to terminal differentiation inhibition. Ad-
ditionally, in small cell lung cancer models, Cx31.1 expression is regu-
lated by autophagy (Zhu et al., 2015).
Cx31.1 has been examined in reproductive tissues, revealing
potential roles in development. Cx31.1 is expressed in the placenta
(Kibschull, Colaco, Matysiak‐Zablocki, Winterhager, & Lye, 2014).
Here, in trophoblast cells, Cx31.1 promotes placental terminal dif-
ferentiation, with Cx31 knock‐out delaying terminal differentiation.
A lack of Cx31.1 also impaired placental development in a further
study (Zheng‐Fischhofer et al., 2007); placenta is a tissue that un-
dergoes rapid tissue turnover. Furthermore, a recent study has
shown that placental Cx31.1 expression is reduced in expression by
high fat diet (Connor et al., 2020). In the testes, Cx31.1 is expressed
in the epididymis where epithelial differentiation alters Cx31.1 ex-
pression profiles (Kidder & Cyr, 2016; Lee, 2016), as does oestradiol
administration (Lee, 2017). Cx31.1 expression in the epididymis is
also developmentally regulated during foetal growth (Lee &
Kim, 2018).
Many studies show a clear correlation between Cx31.1 and
apoptosis, such as that by Chang et al. (2009) in the eye (Chang
et al., 2009) where Cx31.1 is expressed by outer epithelial cells that
are about to sloughed off, and epithelial thickening occurred when
Cx31.1 antisense was used to lower its expression (so those cells
remained in the epithelium even as new layers were added at the
bottom). In the skin, Cx31.1 is expressed continuously in the stratum
granulosum and stratum spinosum layers (Aasen & Kelsell, 2009;
Coutinho, Qiu, Frank, Tamber, & Becker, 2003; Zheng‐Fischhofer
et al., 2007). Cx31.1 expression in the upper layers of the epidermis
could relate to the differentiation programme of keratinocytes at
different cellular levels as they move up through the epidermal cycle
and then detach during sloughing off (Aasen & Kelsell, 2009). In areas
of tissue undergoing apoptosis, there is thought to be an insult
threshold, when cells tip from repairing cell damage to entering into a
death pathway, depending on the extent of the insult. Cells may
switch on Cx31.1 at this tipping point. This was seen in ovarian fol-
licles where the granulosa compartments of dying follicles all ex-
pressed Cx31.1 in a coordinated manner, and stopped expressing
Cx43 (Wright et al., 2001). The point at which this occurs will depend
on stimulus strength and there could be coordinated or un-
coordinated responses depending on tissue and environment. The
switch on of Cx31.1 may help the cell isolate itself from surrounding
cells by closing down GJIC. Thus the health of other cells in the tissue
would be preserved.
The purpose of Cx31.1 functioning to block cell–cell commu-
nication may be to act in concert with other connexins which
downregulate to perform similar actions. Connexins have a short
half‐life (a matter of hours) and are constantly turning over. It is
possible that as cells lose communication, the connexin turnover also
slows down to preserve gap junctions or hemichannels that are still
active. So, if a cell wants to isolate quickly, it could increase pro-
duction of nonfunctional Cx31.1 to prevent any residual GJIC. Musil,
Le, VanSlyke, and Roberts (2000) observed differing rates of Cx43
turnover (Musil et al., 2000) and we have also seen reductions in
communication with connexin mimetic peptides as well as full pre-
vention (Wright et al., 2009, 2012). This suggests cells producing
specific "cell death connexins" would be feasible, and cells under
stress in diabetic conditions would be expected to produce more
Cx31.1 than those in more viable circumstances.
We conclude that Cx31.1 is modulated in this epidermal wound
healing model under ‘diabetic’ conditions. Cx31.1 appears to corre-
late with apoptosis in the HaCaT cells, and as apoptosis is raised in
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diabetic skin, it is possible that Cx31.1 expression would be modu-
lated in wound edges during diabetic (and normal) wound healing.
Future studies will confirm any potential association of Cx31.1 with
tissue turn‐over in diabetic wounds.
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